A systems-level framework for drug discovery identifies Csf1R as an anti-epileptic drug target.

ABSTRACT: The identification of drug targets is highly challenging, particularly for diseases of the brain. To address this problem, we developed and experimentally validated a general computational framework for drug target discovery that combines gene regulatory information with causal reasoning ("Causal Reasoning Analytical Framework for Target discovery"-CRAFT). Using a systems genetics approach and starting from gene expression data from the target tissue, CRAFT provides a predictive framework for identifying cell membrane receptors with a direction-specified influence over disease-related gene expression profiles. As proof of concept, we applied CRAFT to epilepsy and predicted the tyrosine kinase receptor Csf1R as a potential therapeutic target. The predicted effect of Csf1R blockade in attenu

SUBMITTER: Srivastava PK 

PROVIDER: S-EPMC6120885 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature